C000237407 Fees and Costs — Allspring Dynamic Target 2065 Fund, Administrator Class

Data updated: 2024-01-26

The net expense ratio is 0.49% (3.67% before fee waivers). There are no sales loads or redemption fees. In fiscal 2023 the fund paid $533 in broker commissions, 0.0106% of average net assets, and portfolio turnover was 38%.

C000237407 Fees and Expenses

Annual operating expenses and sales charges of C000237407. Prospectus, as of June 30, 2023.

Annual operating expenses
Management fee0.10%
12b-1 fee0.00%
Other expenses3.44%
Gross expense ratio3.67%
Fee waiver−3.18%
Net expense ratio0.49%
Sales charges
Max front load0.00%
Max deferred load0.00%
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

C000237407 Costs Over Time

On $10,000 invested in C000237407, assuming 5% a year before costs, total costs come to $316 over 5 years, cutting the return by 0.53% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.49%)$51$161$281
Trading costs (broker commissions)$1$3$6
Lost growth on money paid in costs$0$8$29
Total costs$53$173$316
Value after costs$10,447$11,403$12,447
Impact on return, per year0.53%0.53%0.53%

C000237407 Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending February 28, 2023.

  • Explicit cost rate (commissions ÷ average net assets): 0.0106%
  • Total broker commissions: $533
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 38%
  • Securities lending: none during the year

C000237407 Agency Brokers

Commissions paid.

BrokerAmountShare
Goldman Sachs & Co. LLC$533100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.